Los puntos clave no están disponibles para este artículo en este momento.
Objective improvement after therapy with melphalan occurred in all patients producing only Bence Jones kappa proteins, in half of the patients with myeloma serum proteins, and in none of those producing only Bence Jones lambda proteins.
Bergsagel et al. (Fri,) studied this question.